BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8281476)

  • 1. Pathophysiology of cardiac dysfunction in congestive heart failure.
    Dhalla NS; Afzal N; Beamish RE; Naimark B; Takeda N; Nagano M
    Can J Cardiol; 1993 Dec; 9(10):873-87. PubMed ID: 8281476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease.
    Dhalla NS; Saini HK; Tappia PS; Sethi R; Mengi SA; Gupta SK
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):238-50. PubMed ID: 17413299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
    Yamaguchi F; Sanbe A; Takeo S
    Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When calcium turns arrhythmogenic: intracellular calcium handling during the development of hypertrophy and heart failure.
    Zaugg CE; Buser PT
    Croat Med J; 2001 Feb; 42(1):24-32. PubMed ID: 11172652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From hypertension to heart failure-a pathophysiological continuum].
    Kilter H; Böhm M
    Herz; 2004 May; 29(3):239-47. PubMed ID: 15167949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure and Starling's Law of the heart.
    ter Keurs HE
    Can J Cardiol; 1996 Oct; 12(10):1047-57. PubMed ID: 9191498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
    J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.
    Dhalla NS; Rangi S; Babick AP; Zieroth S; Elimban V
    Heart Fail Rev; 2012 Sep; 17(4-5):671-81. PubMed ID: 21850540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
    Shah KR; Ganguly PK; Netticadan T; Arneja AS; Dhalla NS
    Can J Physiol Pharmacol; 2004 Jul; 82(7):438-47. PubMed ID: 15389290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects of the pathophysiology of heart failure].
    Pieske B
    Wien Med Wochenschr; 1998; 148(5):108-20. PubMed ID: 9654696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
    Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
    Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoplasmic reticular Ca2+ pump ATPase activity in congestive heart failure due to myocardial infarction.
    Afzal N; Dhalla NS
    Can J Cardiol; 1996 Oct; 12(10):1065-73. PubMed ID: 9191500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction.
    Hassoun SM; Marechal X; Montaigne D; Bouazza Y; Decoster B; Lancel S; Neviere R
    Crit Care Med; 2008 Sep; 36(9):2590-6. PubMed ID: 18679108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.